Solu Therapeutics

BiotechnologySeries ABoston, USsolutherapeutics.com

Latest round

Series A

Last raised

Apr 2025

Total raised

$56M

Investors

10

About Solu Therapeutics

Founded in 2023 by David Donabedian and Brandon Turunen, and based in Massachusetts, US, Solu Therapeutics, Inc. operates as a precision medical technology company that develops precision medicine for the elimination of cells causing various diseases. In April 2025, Solu Therapeutics, Inc. The company uses its proprietary CyTaC platform to create therapies to help treat and eliminate disease-causing cells that cause diseases such as cancer, immunology, and autoimmunity. The company enables the development of next-generation medicines that combine the power of biologics with the vast target binding space of small molecules by unlocking antibody-intractable cell surface targets.

Who invested in Solu Therapeutics

10 investors across 2 rounds

See all investors in Solu Therapeutics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Apr 9, 2025

    Amount

    $40M

    Investors

    Locked

  2. Seed

    May 15, 2023

    Amount

    $16M

    Investors

    Locked

Questions about Solu Therapeutics

Who invested in Solu Therapeutics?

Solu Therapeutics has 10 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Solu Therapeutics raised?

Solu Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Solu Therapeutics last raise money?

Solu Therapeutics's most recent round on record is a Series A, in Apr 2025.

What does Solu Therapeutics do?

Founded in 2023 by David Donabedian and Brandon Turunen, and based in Massachusetts, US, Solu Therapeutics, Inc.

Where is Solu Therapeutics headquartered?

Solu Therapeutics is headquartered in Boston, US.

Which VCs invest in companies like Solu Therapeutics?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Solu Therapeutics's stage. Their profiles are linked below.

Raising like Solu Therapeutics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.